Medscape
WEST PALM BEACH, FLORIDA — A new post hoc analysis of three phase 3 multiple sclerosis (MS) trials in patients with paramagnetic rim lesions (PRLs) suggests that a central nervous system (CNS)–penetrating therapy provides greater relative efficacy in reducing disability when PRLs are present. The analysis included patients with PRLs participating in controlled trials of …
Read More
More Evidence PRLs a Potential Therapeutic Target in MS
Joan Antes
07:20
WEST PALM BEACH, FLORIDA — A new post hoc analysis of three phase 3 multiple sclerosis (MS) trials in patients with paramagnetic rim lesions (PRLs) suggests that a central nervous system (CNS)–penetrating therapy provides greater relative efficacy in reducing disability when PRLs are present. The analysis included patients with PRLs participating in controlled trials of
